Kassandra Munger, ScD, of the Harvard TH Chan School of Public Health, discusses findings that vitamin D deficiencies are linked to a greater risk of multiple sclerosis.
Kassandra Munger, ScD, of the Harvard TH Chan School of Public Health, discusses findings that vitamin D deficiencies are linked to a greater risk of multiple sclerosis.
Transcript:
The associations between vitamin D and MS, they were first shown in the animal studies, which is where we sort of get the inkling that maybe there really was something here, because it had been observed—I'm sure you're aware of the latitude gradient with MS, where, historically, the prevalence of the disease has been higher in the higher latitudes then lower latitudes. Adjusting that sun exposure might have a role and of course, the primary source of vitamin D from people is sun exposure. And you get over the course of a year less sun exposure in more northern latitudes than in latitudes closer to the equator. In the mid 2000s, we decided to take a look at vitamin D intake from diet and risk of MS in our Nurses Health Study cohort. We have 200,000 nurses, many of whom have been supplying us with information on their diets for a number of years among other risk factors, other factors. And in those cohorts, we saw that women who were had a higher intake of vitamin D from supplements had a lower risk of MS. And so even from there to our military study, again, those same samples where we were able to look at [Epstein-Barr virus] EBV, we measured the vitamin D levels. And so in presumably otherwise healthy young individuals, those with higher levels of vitamin D had a lower risk of MS. And then conversely, in the Finnish maternity cohort study, we have a lot of a high percentage of people who were vitamin D deficient, so we’re are able to look at the other end of the scale, if you will. Women who had vitamin D deficiency, and insufficiency in those women, was associated with about a 2-fold increased risk in MS. So we've been able to show the increased risk with low levels of vitamin D, the decreased risk with high levels of vitamin D. Then there have been some other studies which have also shown the same effect.
Specialty Pharmacists at the Forefront: Elevating Care for Rare Diseases
May 1st 2024In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a rare disease at any given time.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
AUA to Focus on Inclusive Care, Robotic Surgeries, and Future of Urology at 2024 Annual Meeting
May 1st 2024The American Urological Association (AUA) 2024 Annual Meeting will highlight the latest innovations and future trends in urology, featuring dynamic plenary sessions, educational opportunities for providers, and discussions on cutting-edge treatments and global health initiatives.
Read More
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More